Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
NCT04568174
First in Human Study to Test the Safety and Preliminary Efficacy of PPSGG in Patients With Anti-MAG Neuropathy
Phase: Phase 1/2
Role: Lead Sponsor
Start: Nov 17, 2020
Completion: Sep 23, 2021